Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
ARArmata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. (ARMP)

New York Stock Exchange Arca · Currency in USD
$3.64 ▲ +0.19 (+5.51%)
At close: Oct 23, 4:00 PM ET. Market closed.

Summary

Previous Close
$3.45
Open
$3.45
Day's Range
$3.44 – $3.79
52 Week Range
$2.75 – $14.98
Volume
115,589
Avg. Volume
203,523
Market Cap
$135.34M
Beta (5Y Monthly)
1.41
PE Ratio (TTM)
--
EPS (TTM)
-$5.23
Earnings Date
Nov 11, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$15.00

Profile: Armata Pharmaceuticals, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
61
CEO
Deborah L. Birx

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform.

Earnings

Next report: Wed, Nov 11, 2026
EPS estimate -$0.57 · Revenue est. $450.00K
DateEst.Actual
Aug 12, 2026-$0.45-$0.27Beat
May 13, 2026-$0.38-$3.16Miss
Mar 25, 2026-$0.19-$3.42Miss
Nov 12, 2025-$0.42-$0.74Miss
Aug 12, 2025-$0.39-$0.45Miss
May 14, 2025-$0.38-$0.20Beat

Analyst view

Consensus price target
$15.00 ▲ +312.1%
Range $15.00 – $15.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Similar stocks

Get free alerts on ARMP and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.